oral glp 1 agonist VisualAbstract: Daily GLP-1 Receptor Orforglipron for Adults with Obesity Current Insights, Advantages and Challenges

Description

Understanding the differences and similarities between these medications can help you and your doctor make informed decisions about treatment options tailored specifically to your individual health goals

Amylin therapies Some drugs currently in development take a different approach, targeting receptors for a different hormone: amylin, which is co-secreted, alongside insulin, by the pancreas to slow gastric emptying, suppress glucagon secretion and signal feelings of fullness

Addiction Weight Loss Drugs May Also Curb Substance Use Disorders GLP-1 drugs affect reward circuits to reduce alcohol, opioid, and nicotine use

Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life